Home/Filings/4/0001225208-18-004948
4//SEC Filing

Phalen Michael P. 4

Accession 0001225208-18-004948

CIK 0000885725other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 4:37 PM ET

Size

12.0 KB

Accession

0001225208-18-004948

Insider Transaction Report

Form 4
Period: 2018-02-28
Phalen Michael P.
SVP & President, Endoscopy
Transactions
  • Exercise/Conversion

    Common Stock

    2018-02-28+5,413134,423 total
  • Exercise/Conversion

    Common Stock

    2018-02-28+2,443136,866 total
  • Tax Payment

    Common Stock

    2018-02-28$27.26/sh3,493$95,219133,373 total
  • Exercise/Conversion

    Deferred Stock Units

    2018-02-282,4439,776 total
    Exp: 2022-02-28Common Stock (2,443 underlying)
  • Exercise/Conversion

    Deferred Stock Units

    2018-02-285,4130 total
    Common Stock (5,413 underlying)
Footnotes (4)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
  • [F3]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
  • [F4]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001483882

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:37 PM ET
Size
12.0 KB